Bevacizumab, atezolizumab and acetylsalicylic acid in recurrent, platinum-resistant ovarian cancer: the EORTC 1508-GCG phase II study
乔垣结衣
25天前
74
10
已完结
1. 系统已在2025-04-02 10:47:35对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1078-0432.CCR-24-3368
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Susana Banerjee; Eleonora Ghisoni; Anita Wolfer; Petronella Beatrix. Ottevanger; Ronan Le Scodan; Apostolos Sarivalasis; Ana Montes; Judith Kroep; Margarita Romeo Marin; Petr Szturz; Matteo Morotti; Julien Dagher; Lana Kandalaft; Fernanda Herrera; Corneel Coens; Denarda Dangaj Laniti; George Coukos
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-24-3368/3557834/ccr-24-3368.pdf
